Rapid fire talk Dynamic Product Labeling Jon Duke MD, MS Regenstrief Institute
Dynamic Product Labeling Overview
Jun 15, 2015
Customizing Drug Product Labeling with Evidence Layers and Personalization
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Rapid fire talk
Dynamic Product LabelingJon Duke MD, MS Regenstrief Institute
Pre-1960 1960-1969 1970-1979 1980-1989 1990-1999 2000-20090
1000
2000
3000
4000
5000
6000
7000
8000
9000
3258 33913841
5317
7458
8160
Date of Drug Approval
Wor
d Co
unt
Drug Labels are Growing Longer
All Drugs
Bisphosphonates
Beta Blockers
Benzodiazepines
NSAIDs
Statins
ACE-Inhibitors
Proton Pump Inhibitors
5-HT1 Agonists (Triptans)
Atypical Antipsychotics
SSRI's
0 50 100 150 200 250 300 350 400
70
103
111
118
121
127
165
185
227
241
384
Mean Number of ADE's per label
Dru
g Cl
ass
Drug Labels are Packed with Warnings
Duke J, Friedlin J, Ryan P. A Quantitative Analysis of Adverse Events and ‘Overwarning’ in Drug Labeling. Archives of Internal Medicine. May 2011;171(10):944-6.
Rapid fire talk
We’ve Got a Global Problem
Kesselheim AS, Franklin JM, Avorn J, Duke J. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs. BMJ Journal of Quality and Safety. 2013 22(9):727-734.
Drug labels have become more relevant toindustry, regulators, researchers, and lawyersthan they are to patients and providers
Dynamic Product Labeling refers to customizing the user experience of a drug label to make it
- More patient-specific- More provider-relevant
Zaxyza
Rapid fire talk
Rapid fire talk
Augmenting the User Experience with Layers
Rapid fire talk
Evidence Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies
+ Patient Data
Zaxyza
Rapid fire talk
Enter drug name
Additional Data Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies
Observational Data Analysis
Abnormal Hepatic Function
with Zaxyza
+ Patient Data
Rapid fire talk
Enter drug name
Additional Data Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies
Literature Evidence onAbnormal Hepatic Function with Zaxyza
3 Randomized Controlled Studies5 Observational Studies11 Case Reports2 Review Papers
+ Patient Data
Rapid fire talk
Enter drug name
Additional Data Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies
+ Patient Data
Rapid fire talk
Enter drug name
Additional Data Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies
Malpractice Cases involvingSeizure and Zaxyza
127 cases on Lexis-Nexis135 cases on Westlaw
87 cases on PACER
+ Patient Data
Rapid fire talk
Enter drug name
Additional Data Layers
Observational Data
Literature Evidence
Adverse Event Reporting
Malpractice / Tort Cases
Provider Historical Data
Ontologies In your patients on Zaxyza
Myalgia has occurred in 4 of 86 patients
+ Patient Data
Rapid fire talk
Dynamic Product Labeling requires a lot knowledge- Knowledge of the evidence (literature, observational data)
- Knowledge of the patient (manual entry, EHR)
Rapid fire talk
- The label customization framework itself is lightweight (Javascript, CSS, HTML5)- Initially targeting SPLs but ultimately extensible
to SPCs and other drug safety content
Rapid fire talk
Thank you.
Related Documents
